Urolithin A and Cholesterol: What the Early Research Suggests

Cholesterol is one of the most-watched numbers in midlife health, so it's natural to wonder whether a cellular-health compound like Urolithin A touches it. The honest answer is: the research is intriguing but early, and it lives mostly in petri dishes and animal models rather than human trials. Understanding exactly what's been shown — and what hasn't — is the only responsible way to read this topic.

What is the connection between Urolithin A and cholesterol?

The mechanistic link runs through AMPK, a cellular sensor that helps regulate energy balance and lipid metabolism. When AMPK is active, cells tend to shift away from storing fats and cholesterol. Urolithin A has been shown to activate AMPK in laboratory settings, and that pathway is also involved in how cells manage cholesterol transport.

The clearest example comes from a 2020 study in Food & Function, which used cultured mouse macrophages (immune cells that, when overloaded with cholesterol, become the "foam cells" central to artery plaque). In that model, Urolithin A reduced cholesterol buildup and promoted cholesterol efflux — the process of moving cholesterol out of cells — by activating AMPK and increasing the cholesterol-transport proteins ABCA1 and ABCG1 (PRECLINICAL, in vitro).

What does "cholesterol efflux" actually mean?

Efflux is the cell's way of exporting excess cholesterol so it can be carried back to the liver for disposal. Healthy efflux is generally considered protective. Showing that a compound supports efflux in cultured cells is a promising mechanistic signal — but cultured cells are a long way from a human bloodstream, which is why this stays firmly in the "early" category.

What have animal studies shown?

Moving one step closer to a whole organism, a 2020 study in Diabetes, Metabolic Syndrome and Obesity fed rats a high-fat diet and reported that urolithins attenuated multiple features of diet-induced obesity, including improvements in lipid-related markers (PRECLINICAL). The compound's broader metabolic effects are thought to tie back to its signature action — supporting mitochondrial quality through mitophagy, first detailed in Ryu and colleagues' 2016 Nature Medicine paper (PRECLINICAL). Mitochondria are where fatty acids are ultimately burned, so a compound that supports mitochondrial function has a plausible, if indirect, metabolic rationale.

What do human studies say about cholesterol?

This is where honesty is essential: the major human Urolithin A trials were not designed around cholesterol. The 2019 first-in-human trial in Nature Metabolism measured safety and mitochondrial-related plasma markers, including acylcarnitines that reflect how the body handles fats for fuel — but that's fat metabolism, not blood cholesterol (HUMAN). The 2022 randomized trial in Cell Reports Medicine tracked muscle and cellular-health biomarkers (including C-reactive protein, an inflammation marker), again not a cholesterol-focused endpoint (HUMAN).

So while the mechanistic and animal data hint at a role in cholesterol handling, there is currently no large, well-controlled human trial showing that Urolithin A lowers LDL or total cholesterol. Anyone who tells you otherwise is getting ahead of the evidence.

Why do cholesterol and mitochondria get mentioned together?

The thread connecting them is metabolic health. Mitochondrial dysfunction is one of the recognized hallmarks of aging described in the 2023 Hallmarks of Aging framework, and declining mitochondrial efficiency is intertwined with how the body processes fats and sugars as we age (review). When mitochondria burn fatty acids less efficiently, lipids can accumulate — which is the loose rationale for why a mitophagy-supporting compound might, in theory, intersect with lipid handling.

But "in theory" is the operative phrase. A plausible biological story is not the same as a measured effect in people. The human data we do have, such as the 2022 JAMA Network Open trial in older adults, centered on muscle endurance and mitochondrial plasma biomarkers rather than lipid panels (HUMAN). Cholesterol simply hasn't been a primary endpoint in the major trials.

How should you think about this?

Treat Urolithin A as a cellular-health supplement with interesting early metabolic signals — not as anything resembling a cholesterol product. If managing cholesterol is your goal, the proven levers are diet, exercise, weight management, and, when appropriate, medications prescribed and monitored by your clinician. Urolithin A does not replace any of that.

For people already interested in cellular energy and healthy aging, the muscle and mitochondrial research is the stronger reason to consider it. SOMA Urolithin A gummies deliver a standardized 1,000 mg daily dose for that purpose. If you have high cholesterol or take lipid-lowering medication, talk with your healthcare provider before adding any supplement.

Frequently asked questions

Does Urolithin A lower cholesterol?

There is no robust human evidence that it does. The cholesterol-related findings so far come from cell and animal studies, which don't reliably predict human results. It should not be used to manage cholesterol.

What's the mechanism people point to?

In lab studies, Urolithin A activates AMPK and supports cholesterol efflux — the export of cholesterol out of cells. That's a plausible mechanism, but mechanism alone doesn't prove a clinical effect in people.

Can I take it with a statin?

That's a question for your clinician. Because Urolithin A hasn't been studied specifically alongside cholesterol medications in large trials, your prescriber should weigh in before you combine them.

Is the cholesterol research strong enough to rely on?

No. It's early-stage and mostly preclinical. It's reasonable to find it interesting, but not to base cholesterol decisions on it.

Why take Urolithin A at all, then?

The stronger human evidence is around muscle endurance, strength measures, and mitochondrial-health biomarkers. Cholesterol is a speculative, early side-topic — not the main reason the compound is studied.

SOMA Health

Support your cellular health, every day

SOMA delivers a high-potency 1,000 mg dose of Urolithin A in one simple daily gummy — no guesswork, no converter-status lottery.

Shop SOMA Urolithin A Gummies →